Skip to main content
. Author manuscript; available in PMC: 2013 May 13.
Published in final edited form as: Eur J Pharm Biopharm. 2012 Sep 25;83(1):106–113. doi: 10.1016/j.ejpb.2012.09.005

Table 2.

Measurement of biological activity of the released inhibitors, using an enzyme linked sorbent assay. The results were expressed as a percentage activity of TG compared to positive control (without the inhibitor). Results denote mean ±SD from 3 independently synthesized batches.

% activity of TG
% reduction in activity of
TG
Inhibitor (w/w) 1 % 0.5 % 1 % 0.5 %
time

1 Day 9.12 16.06 90.88 83.94
1 week 6.55 12.06 93.45 87.94
2 week 54.34 57.90 45.66 42.10
3 week 46.16 50.23 53.84 49.77
4 week 78.30 82.20 21.70 17.80